FDA approves drug combination for treating mesothelioma
from U.S. Food & Drug Administration
On Oct. 2, the U.S. Food and Drug Administration approved Opdivo in combination with Yervoy for the first-line treatment of adults with malignant pleural mesothelioma that cannot be removed by surgery. This is the first drug regimen approved for mesothelioma in 16 years and the second FDA-approved systemic therapy for mesothelioma.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063